HDL Cholesterol Efflux and Serum Cholesterol Loading Capacity Alterations Associate to Macrophage Cholesterol Accumulation in FH Patients with Achilles Tendon Xanthoma.
Achilles tendon
HDL cholesterol efflux
macrophage
serum cholesterol loading
xanthoma
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
26 Jul 2022
26 Jul 2022
Historique:
received:
28
06
2022
revised:
22
07
2022
accepted:
24
07
2022
entrez:
28
7
2022
pubmed:
29
7
2022
medline:
30
7
2022
Statut:
epublish
Résumé
Achilles tendon xanthoma (ATX) formation involves macrophage cholesterol accumulation within the tendon, similar to that occurring in atheroma. Macrophage cholesterol homeostasis depends on serum lipoprotein functions, namely the high-density lipoprotein (HDL) capacity to promote cell cholesterol efflux (cholesterol efflux capacity, CEC) and the serum cholesterol loading capacity (CLC). We explored the HDL-CEC and serum CLC, comparing 16 FH patients with ATX to 29 FH patients without ATX. HDL-CEC through the main efflux mechanisms mediated by the transporters ATP binding cassette G1 (ABCG1) and A1 (ABCA1) and the aqueous diffusion (AD) process was determined by a cell-based radioisotopic technique and serum CLC fluorimetrically. Between the two groups, no significant differences were found in terms of plasma lipid profile. A trend toward reduction of cholesterol efflux via AD and a significant increase in ABCA1-mediated HDL-CEC (+18.6%) was observed in ATX compared to no ATX patients. In ATX-presenting patients, ABCG1-mediated HDL-CEC was lower (−11%) and serum CLC was higher (+14%) compared to patients without ATX. Considering all the patients together, ABCG1 HDL-CEC and serum CLC correlated with ATX thickness inversely (p = 0.013) and directly (p < 0.0001), respectively. In conclusion, lipoprotein dysfunctions seem to be involved in ATX physiopathology and progression in FH patients.
Identifiants
pubmed: 35897824
pii: ijms23158255
doi: 10.3390/ijms23158255
pmc: PMC9332368
pii:
doi:
Substances chimiques
ATP Binding Cassette Transporter 1
0
ATP Binding Cassette Transporter, Subfamily G, Member 1
0
Cholesterol, HDL
0
Lipoproteins
0
Cholesterol
97C5T2UQ7J
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Anatol J Cardiol. 2017 Aug;18(2):149-154
pubmed: 28766509
Eur Heart J. 2013 Dec;34(45):3478-90a
pubmed: 23956253
Heart Vessels. 2019 Oct;34(10):1595-1599
pubmed: 30968218
FEBS Lett. 2005 Dec 5;579(29):6537-42
pubmed: 16289478
Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):181-8
pubmed: 26543100
Eur J Clin Invest. 2005 Apr;35(4):236-44
pubmed: 15816992
Circ Res. 2018 Jan 5;122(1):106-112
pubmed: 29018035
J Clin Lipidol. 2019 Jan - Feb;13(1):40-48
pubmed: 30503304
J Lipid Res. 2005 Oct;46(10):2246-53
pubmed: 16061948
Atherosclerosis. 2020 Jun;302:36-42
pubmed: 32438197
PLoS One. 2018 Jun 21;13(6):e0199645
pubmed: 29928054
Adv Exp Med Biol. 2016;920:151-65
pubmed: 27535257
Lipids Health Dis. 2022 May 28;21(1):47
pubmed: 35643463
Acta Med Scand. 1975 Sep;198(3):183-95
pubmed: 1180126
J Lipids. 2021 Apr 26;2021:5585521
pubmed: 33996157
J Atheroscler Thromb. 2011;18(8):698-704
pubmed: 21512280
Atherosclerosis. 2021 Apr;323:44-53
pubmed: 33836456
Eur Heart J. 2015 Sep 21;36(36):2425-37
pubmed: 26009596
Eur Heart J. 2015 Feb 21;36(8):482-9c
pubmed: 25433021
J Lipid Res. 2012 May;53(5):984-989
pubmed: 22414482
J Lipid Res. 2006 Mar;47(3):605-13
pubmed: 16327021
Circulation. 1995 Aug 1;92(3):290-5
pubmed: 7634440
Eur Heart J. 2003 Oct;24(19):1756-62
pubmed: 14522571
Atherosclerosis. 2017 Aug;263:393-397
pubmed: 28499609
Cardiovasc Res. 2013 Oct 1;100(1):36-43
pubmed: 23812298
Drug Discov Today. 2018 Jan;23(1):171-180
pubmed: 28986138
Ann Rheum Dis. 2014 Mar;73(3):609-15
pubmed: 23562986
J Endocr Soc. 2020 Aug 21;5(1):bvaa122
pubmed: 33928199
Circulation. 2021 Jun 8;143(23):2293-2309
pubmed: 34097448
Atheroscler Suppl. 2020 Dec;42:e35-e40
pubmed: 33589222
Nature. 2021 Apr;592(7855):524-533
pubmed: 33883728
Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2439-2445
pubmed: 27765764
Atherosclerosis. 2009 Dec;207(2):311-7
pubmed: 19439299
FEBS Lett. 2005 Aug 15;579(20):4503-12
pubmed: 16083882
Eur J Prev Cardiol. 2018 Nov;25(17):1843-1851
pubmed: 30058841
Curr Rheumatol Rep. 2017 Nov 4;19(12):76
pubmed: 29101577
Biomedicines. 2021 Jul 13;9(7):
pubmed: 34356876
J Dermatol Sci. 2002 Dec;30(3):248-55
pubmed: 12443848
J Cardiol. 2020 Jun;75(6):654-658
pubmed: 31992496
Curr Opin Cardiol. 2017 Jul;32(4):454-459
pubmed: 28426445
Biochim Biophys Acta Mol Cell Biol Lipids. 2022 Apr;1867(4):159119
pubmed: 35121104
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3097-3107
pubmed: 30835274
PLoS One. 2015 Apr 13;10(4):e0121516
pubmed: 25875611
Curr Opin Lipidol. 2012 Jun;23(3):182-189
pubmed: 22488423
J Lipid Res. 2009 Feb;50(2):275-84
pubmed: 18827283
J Lipid Res. 2017 Oct;58(10):2051-2060
pubmed: 28830907
Cells. 2021 Mar 05;10(3):
pubmed: 33807918
Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1960-5
pubmed: 16020744
Am J Epidemiol. 2004 Sep 1;160(5):421-9
pubmed: 15321838
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
Atherosclerosis. 2014 Mar;233(1):219-23
pubmed: 24529147
Curr Atheroscler Rep. 2021 Apr 29;23(6):29
pubmed: 33914189
Dermatology. 1996;193(1):27-32
pubmed: 8864614
Biosci Rep. 2019 Apr 2;39(4):
pubmed: 30867253
Eur Heart J. 2017 May 21;38(20):1573-1579
pubmed: 28159968
J Am Heart Assoc. 2022 Apr 5;11(7):e023668
pubmed: 35322671
Crit Rev Biochem Mol Biol. 2021 Aug;56(4):426-439
pubmed: 34182846